Effect of abrocitinib on skin biomarkers in patients with moderate-to-severe atopic dermatitis. Guttman-Yassky E, Facheris P, Gomez-Arias PJ, Del Duca E, et al. Allergy 2023 Dec 18. doi: 10.1111/all.15969.

Read + Share

Amedeo Smart

Independent Medical Education

Guttman-Yassky E, Facheris P, Gomez-Arias PJ, Del Duca E, et al. Effect of abrocitinib on skin biomarkers in patients with moderate-to-severe atopic dermatitis. Allergy 2023 Dec 18. doi: 10.1111/all.15969.
PMID: 38108208